Your browser doesn't support javascript.
loading
Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes.
Haberger, Markus; Bomans, Katrin; Diepold, Katharina; Hook, Michaela; Gassner, Jana; Schlothauer, Tilman; Zwick, Adrian; Spick, Christian; Kepert, Jochen Felix; Hienz, Brigitte; Wiedmann, Michael; Beck, Hermann; Metzger, Philipp; Mølhøj, Michael; Knoblich, Constanze; Grauschopf, Ulla; Reusch, Dietmar; Bulau, Patrick.
Afiliación
  • Haberger M; Pharma Technical Development Penzberg; Roche Diagnostics GmbH; Penzberg, Germany.
  • Bomans K; Pharma Technical Development Penzberg; Roche Diagnostics GmbH; Penzberg, Germany.
  • Diepold K; Pharma Technical Development Penzberg; Roche Diagnostics GmbH; Penzberg, Germany.
  • Hook M; Pharma Technical Development Penzberg; Roche Diagnostics GmbH; Penzberg, Germany.
  • Gassner J; Pharma Technical Development Penzberg; Roche Diagnostics GmbH; Penzberg, Germany.
  • Schlothauer T; Pharma Research and Early Development; Roche Diagnostics GmbH; Penzberg, Germany.
  • Zwick A; Pharma Research and Early Development; Roche Diagnostics GmbH; Penzberg, Germany.
  • Spick C; Pharma Research and Early Development; Roche Diagnostics GmbH; Penzberg, Germany.
  • Kepert JF; Pharma Technical Development Penzberg; Roche Diagnostics GmbH; Penzberg, Germany.
  • Hienz B; Pharma Technical Development Penzberg; Roche Diagnostics GmbH; Penzberg, Germany.
  • Wiedmann M; Pharma Technical Development Penzberg; Roche Diagnostics GmbH; Penzberg, Germany.
  • Beck H; Pharma Technical Development Basel; F. Hoffmann-La Roche Ltd; Basel, Switzerland.
  • Metzger P; Pharma Technical Development Basel; F. Hoffmann-La Roche Ltd; Basel, Switzerland.
  • Mølhøj M; Pharma Research and Early Development; Roche Diagnostics GmbH; Penzberg, Germany.
  • Knoblich C; Pharma Technical Development Basel; F. Hoffmann-La Roche Ltd; Basel, Switzerland.
  • Grauschopf U; Pharma Technical Development Penzberg; Roche Diagnostics GmbH; Penzberg, Germany.
  • Reusch D; Pharma Technical Development Penzberg; Roche Diagnostics GmbH; Penzberg, Germany.
  • Bulau P; Pharma Technical Development Penzberg; Roche Diagnostics GmbH; Penzberg, Germany.
MAbs ; 6(2): 327-39, 2014.
Article en En | MEDLINE | ID: mdl-24441081
Modifications like asparagine deamidation, aspartate isomerization, methionine oxidation, and lysine glycation are typical degradations for recombinant antibodies. For the identification and functional evaluation of antibody critical quality attributes (CQAs) derived from chemical modifications in the complementary-determining regions (CDRs) and the conserved regions, an approach employing specific stress conditions, elevated temperatures, pH, oxidizing agents, and forced glycation with glucose incubation, was applied. The application of the specific stress conditions combined with ion exchange chromatography, proteolytic peptide mapping, quantitative liquid chromatography mass spectrometry, and functional evaluation by surface plasmon resonance analysis was adequate to identify and functionally assess chemical modification sites in the CDRs of a recombinant IgG1. LC-Met-4, LC-Asn-30/31, LC-Asn-92, HC-Met-100c, and HC Lys-33 were identified as potential CQAs. However, none of the assessed degradation products led to a complete loss of functionality if only one light or heavy chain of the native antibody was affected.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mapeo Peptídico / Proteínas Recombinantes / Inmunoglobulina G / Productos Finales de Glicación Avanzada / Regiones Determinantes de Complementariedad Límite: Humans Idioma: En Revista: MAbs Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mapeo Peptídico / Proteínas Recombinantes / Inmunoglobulina G / Productos Finales de Glicación Avanzada / Regiones Determinantes de Complementariedad Límite: Humans Idioma: En Revista: MAbs Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos